01 October 2003
Delirium due to Buprenorphine therapy
Alexander Kaptsan , Darwin TeliasCase Rep Clin Pract Rev 2003; 4(3):182-185 :: ID: 450617
Abstract
Background: Buprenorphine, a mixed agonist-antagonist opioid, is a potent analgesic that appears to be effective for the maintenance treatment of opiate abuse. We did not find published reports of buprenorphine-induced delirium in opioid users and now describe a patient who developed delirium probably due to buprenorphine treatment.
Case report: The following report describes a case in which a physically healthy patient suffering from opioid abuse developed delirium under buprenorphine therapy. The patient was confused, had visual and verbal hallucinations, delusions of reference, influence and persecution, which were successfully treated by termination of buprenorphine and treatment with haloperidol.
Conclusions: The intention of this report is to draw new attention to the adverse event, which may represent a dangerous side effect of treatment with a relatively novel medication. Some speculations about possible mechanisms and clinical implication are discussed. Further systematic study would be required, if a significant number of cases.
Keywords: Buprenorphine, side effect, Delirium
1,840
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953653
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952921
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953836
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953506
Most Viewed Current Articles
07 Dec 2021 : Case report
22,773,072
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
179,002
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
122,896
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
67,375
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






